To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - TR-1: Notification of major interest in shares

Release Date: 23/09/2016 12:00
Code(s): MEI     PDF:  
Wrap Text
TR-1: Notification of major interest in shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88


23 September 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


 1. Identity of the issuer or the underlying issuer
 of existing shares to which voting rights are                  MEDICLINIC INTERNATIONAL PLC
 attached:

 2. Reason for the notification (please tick the appropriate box or boxes):

 An acquisition or disposal of voting rights                                               X

 An acquisition or disposal of qualifying financial instruments which may result in the acquisition
 of shares already issued to which voting rights are attached
 An acquisition or disposal of instruments with similar economic effect to qualifying financial
 instruments

 An event changing the breakdown of voting rights

 Other (please
 specify):


 3. Full name of person(s) subject to the              PUBLIC INVESTMENT CORPORATION SOC
 notification obligation:                                            LIMITED




 4. Full name of shareholder(s)
                                                                             N/A
 (if different from 3.):


 5. Date of the transaction and date on
 which the threshold is crossed or                                   21 September 2016
 reached:

 6. Date on which issuer notified:                                   22 September 2016

 7. Threshold(s) that is/are crossed or
                                                                             8%
 reached:

 8. Notified details:

 A: Voting rights attached to shares
 Class/type      Situation previous         Resulting situation after the triggering transaction
 of              to the triggering
 shares          transaction
                 Number         Number      Number       Number of voting      % of voting rights
 if possible     of             of          of shares    rights
 using           Shares         Voting
 the ISIN                       Rights      Direct       Direct     Indirect   Direct      Indirect
 CODE


MEI
ORDINARY        54 981 809                 59 239 493                         8.035%
SHARES




 B: Qualifying Financial Instruments

 Resulting situation after the triggering transaction
 Type of financial      Expiration   Exercise/                Number of voting            % of voting
 instrument             date         Conversion Period        rights that may be          rights
                                                              acquired if the
                                                              instrument is
                                                              exercised/ converted


 NONE                   N/A          N/A                      N/A                         N/A




 C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

 Resulting situation after the triggering transaction
 Type of        Exercise       Expiration   Exercise/     Number of voting     % of voting rights
 financial      price          date         Conversion    rights instrument
 instrument                                 period        refers to
                                                                              Nominal     Delta




 Total (A+B+C)

 Number of voting rights                             Percentage of voting rights

 59 239 493                                          8.035%
 
 9. Chain of controlled undertakings through which the voting rights and/or the
 financial instruments are effectively held, if applicable:


 N/A




 Proxy Voting:

 10. Name of the proxy holder:                                   N/A


 11. Number of voting rights proxy holder will cease
                                                                 N/A
 to hold:


 12. Date on which proxy holder will cease to hold
                                                                 N/A
 voting rights:




 13. Additional information:                      N/A



 14. Contact name:                                DEVILLIERS MAKONKO


 15. Contact telephone number:                    012 742 3578


Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 23/09/2016 12:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story